vs
AXCELIS TECHNOLOGIES INC（ACLS）与亚什兰（ASH）财务数据对比。点击上方公司名可切换其他公司
亚什兰的季度营收约是AXCELIS TECHNOLOGIES INC的1.6倍（$386.0M vs $238.3M），AXCELIS TECHNOLOGIES INC净利率更高（14.4% vs -3.1%，领先17.5%），亚什兰同比增速更快（-4.7% vs -5.6%），亚什兰自由现金流更多（$111.0M vs $-8.9M），过去两年AXCELIS TECHNOLOGIES INC的营收复合增速更高（-2.8% vs -18.1%）
Axcelis Technologies是一家美国半导体设备供应商，1995年成立，总部位于美国马萨诸塞州贝弗利。公司面向全球半导体制造行业，从事半导体生产核心设备的设计、制造及服务，主营产品包括高中电流、高能离子注入系统以及半导体芯片制造用固化系统。
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
ACLS vs ASH — 直观对比
营收规模更大
ASH
是对方的1.6倍
$238.3M
营收增速更快
ASH
高出0.9%
-5.6%
净利率更高
ACLS
高出17.5%
-3.1%
自由现金流更多
ASH
多$119.9M
$-8.9M
两年增速更快
ACLS
近两年复合增速
-18.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $238.3M | $386.0M |
| 净利润 | $34.3M | $-12.0M |
| 毛利率 | 47.0% | 27.2% |
| 营业利润率 | 15.2% | -1.6% |
| 净利率 | 14.4% | -3.1% |
| 营收同比 | -5.6% | -4.7% |
| 净利润同比 | -31.3% | 92.7% |
| 每股收益（稀释后） | $1.11 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACLSASH
| Q4 25 | $238.3M | $386.0M | ||
| Q3 25 | $213.6M | $477.0M | ||
| Q2 25 | $194.5M | $463.0M | ||
| Q1 25 | $192.6M | $479.0M | ||
| Q4 24 | $252.4M | $405.0M | ||
| Q3 24 | $256.6M | $521.0M | ||
| Q2 24 | $256.5M | $544.0M | ||
| Q1 24 | $252.4M | $575.0M |
净利润ACLSASH
| Q4 25 | $34.3M | $-12.0M | ||
| Q3 25 | $26.0M | $31.0M | ||
| Q2 25 | $31.4M | $-742.0M | ||
| Q1 25 | $28.6M | $31.0M | ||
| Q4 24 | $50.0M | $-165.0M | ||
| Q3 24 | $48.6M | $17.0M | ||
| Q2 24 | $50.9M | $6.0M | ||
| Q1 24 | $51.6M | $120.0M |
毛利率ACLSASH
| Q4 25 | 47.0% | 27.2% | ||
| Q3 25 | 41.6% | 33.3% | ||
| Q2 25 | 44.9% | 28.5% | ||
| Q1 25 | 46.1% | 30.7% | ||
| Q4 24 | 46.0% | 27.4% | ||
| Q3 24 | 42.9% | 33.2% | ||
| Q2 24 | 43.8% | 34.2% | ||
| Q1 24 | 46.0% | 28.0% |
营业利润率ACLSASH
| Q4 25 | 15.2% | -1.6% | ||
| Q3 25 | 11.7% | 12.8% | ||
| Q2 25 | 14.9% | -152.9% | ||
| Q1 25 | 15.1% | 10.6% | ||
| Q4 24 | 21.6% | -44.2% | ||
| Q3 24 | 18.3% | 6.1% | ||
| Q2 24 | 20.6% | -11.2% | ||
| Q1 24 | 22.4% | 3.7% |
净利率ACLSASH
| Q4 25 | 14.4% | -3.1% | ||
| Q3 25 | 12.2% | 6.5% | ||
| Q2 25 | 16.1% | -160.3% | ||
| Q1 25 | 14.8% | 6.5% | ||
| Q4 24 | 19.8% | -40.7% | ||
| Q3 24 | 18.9% | 3.3% | ||
| Q2 24 | 19.8% | 1.1% | ||
| Q1 24 | 20.4% | 20.9% |
每股收益（稀释后）ACLSASH
| Q4 25 | $1.11 | $-0.26 | ||
| Q3 25 | $0.83 | $0.83 | ||
| Q2 25 | $0.98 | $-16.21 | ||
| Q1 25 | $0.88 | $0.65 | ||
| Q4 24 | $1.54 | $-3.50 | ||
| Q3 24 | $1.49 | $0.34 | ||
| Q2 24 | $1.55 | $0.12 | ||
| Q1 24 | $1.57 | $2.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $374.3M | $304.0M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $1.0B | $1.9B |
| 总资产 | $1.4B | $4.5B |
| 负债/权益比越低杠杆越低 | — | 0.74× |
8季度趋势，按日历期对齐
现金及短期投资ACLSASH
| Q4 25 | $374.3M | $304.0M | ||
| Q3 25 | $449.6M | $215.0M | ||
| Q2 25 | $549.8M | $207.0M | ||
| Q1 25 | $587.1M | $168.0M | ||
| Q4 24 | $571.3M | $219.0M | ||
| Q3 24 | $579.4M | $300.0M | ||
| Q2 24 | $548.3M | $399.0M | ||
| Q1 24 | $530.2M | $439.0M |
总债务ACLSASH
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.3B |
股东权益ACLSASH
| Q4 25 | $1.0B | $1.9B | ||
| Q3 25 | $1.0B | $1.9B | ||
| Q2 25 | $1.0B | $1.9B | ||
| Q1 25 | $1.0B | $2.6B | ||
| Q4 24 | $1.0B | $2.6B | ||
| Q3 24 | $975.6M | $2.9B | ||
| Q2 24 | $934.9M | $3.0B | ||
| Q1 24 | $901.7M | $3.1B |
总资产ACLSASH
| Q4 25 | $1.4B | $4.5B | ||
| Q3 25 | $1.4B | $4.6B | ||
| Q2 25 | $1.3B | $4.6B | ||
| Q1 25 | $1.3B | $5.2B | ||
| Q4 24 | $1.3B | $5.2B | ||
| Q3 24 | $1.3B | $5.6B | ||
| Q2 24 | $1.3B | $5.7B | ||
| Q1 24 | $1.3B | $5.9B |
负债/权益比ACLSASH
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.73× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 0.52× | ||
| Q4 24 | — | 0.51× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 0.45× | ||
| Q1 24 | — | 0.42× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $125.0M |
| 自由现金流经营现金流 - 资本支出 | $-8.9M | $111.0M |
| 自由现金流率自由现金流/营收 | -3.7% | 28.8% |
| 资本支出强度资本支出/营收 | 1.0% | 3.6% |
| 现金转化率经营现金流/净利润 | -0.19× | — |
| 过去12个月自由现金流最近4个季度 | $107.0M | $200.0M |
8季度趋势，按日历期对齐
经营现金流ACLSASH
| Q4 25 | $-6.6M | $125.0M | ||
| Q3 25 | $45.4M | $40.0M | ||
| Q2 25 | $39.7M | $115.0M | ||
| Q1 25 | $39.8M | $9.0M | ||
| Q4 24 | $12.8M | $-30.0M | ||
| Q3 24 | $45.7M | $80.0M | ||
| Q2 24 | $40.1M | $127.0M | ||
| Q1 24 | $42.2M | $54.0M |
自由现金流ACLSASH
| Q4 25 | $-8.9M | $111.0M | ||
| Q3 25 | $43.3M | $6.0M | ||
| Q2 25 | $37.7M | $95.0M | ||
| Q1 25 | $34.8M | $-12.0M | ||
| Q4 24 | $8.1M | $-53.0M | ||
| Q3 24 | $41.8M | $42.0M | ||
| Q2 24 | $38.1M | $98.0M | ||
| Q1 24 | $40.6M | $20.0M |
自由现金流率ACLSASH
| Q4 25 | -3.7% | 28.8% | ||
| Q3 25 | 20.3% | 1.3% | ||
| Q2 25 | 19.4% | 20.5% | ||
| Q1 25 | 18.1% | -2.5% | ||
| Q4 24 | 3.2% | -13.1% | ||
| Q3 24 | 16.3% | 8.1% | ||
| Q2 24 | 14.8% | 18.0% | ||
| Q1 24 | 16.1% | 3.5% |
资本支出强度ACLSASH
| Q4 25 | 1.0% | 3.6% | ||
| Q3 25 | 0.9% | 7.1% | ||
| Q2 25 | 1.0% | 4.3% | ||
| Q1 25 | 2.6% | 4.4% | ||
| Q4 24 | 1.8% | 5.7% | ||
| Q3 24 | 1.5% | 7.3% | ||
| Q2 24 | 0.8% | 5.3% | ||
| Q1 24 | 0.6% | 5.9% |
现金转化率ACLSASH
| Q4 25 | -0.19× | — | ||
| Q3 25 | 1.75× | 1.29× | ||
| Q2 25 | 1.27× | — | ||
| Q1 25 | 1.39× | 0.29× | ||
| Q4 24 | 0.26× | — | ||
| Q3 24 | 0.94× | 4.71× | ||
| Q2 24 | 0.79× | 21.17× | ||
| Q1 24 | 0.82× | 0.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACLS
| Products | $224.6M | 94% |
| Services | $13.7M | 6% |
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
